Strut Health review: oral semaglutide lozenges $99-$149/mo, injectable $189-$289/mo, FDA warning letter Feb 2026, D+ BBB rating, cancellation friction. Compared to PlexusDx Microdose GLP-1 ($129/mo), Semaglutide Injection ($189/mo), and Tirzepatide Injection ($289/mo) with the optional Precision Peptide Genetic Test for dose personalization.

Compounding pharmacy shut down or lost 503A status for GLP-1s? A 2026 patient continuity guide: first 24-hour checklist, the four scenarios, what a warning letter actually means, three pharmacy-verification lookups, and how PlexusDx Semaglutide Injection ($189/mo), Tirzepatide Injection ($289/mo), Microdose GLP-1 Protocol ($129/mo), GLP-Squared ($289/mo), and the Precision Peptide Genetic Test ($298) handle transfer patients.

An honest, verified review of Skinny Rx tirzepatide tablets — the $299/month buccal-dissolve compounded product, the February 2026 FDA warning letter, and the actual evidence picture for any oral tirzepatide formulation — with a feature-by-feature comparison to PlexusDx Tirzepatide Oral Protocol ($349/mo, 5mg to 25mg daily across seven dose levels) as the cash-pay alternative.

MEDVi, Remedy Meds and PlexusDx all offer compounded semaglutide and tirzepatide injections through telehealth, but their recurring prices, first-month structures, cancellation windows and refund rules differ. This three-way comparison lines up the published figures, marks what each provider leaves unpublished, and matches each program to a specific priority.

MEDVi vs Gala GLP-1 vs PlexusDx compared on verified 2026 pricing, compounded vs FDA-approved status, cancellation rules, and where a genetic baseline changes the dose decision before week one.